Overall, our findings highlight the anti‐cancer properties of c‐Myc‐i7, c‐Myc‐i7 and c‐Myc‐i10 across four different cancer types, as evidenced by their remarkable reductions in cell viability (Figure 1G). This evidence concerns the gene MYC and cancer.